Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three Cases

Leptomeningeal metastases (LM) occur in 3–5% of patients with advanced non-small-cell lung cancer (NSCLC) and are associated with a dismal prognosis. We report three cases of NSCLC with LM who were treated with the combination of nimotuzumab and erlotinib. Magnetic Resonance Imaging (MRI) evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hongyu, Zhou, Lin, Lu, You, Su, Xiaomei, Cheng, Peng, Li, Dong, Gao, Hui, Li, Hua, Yuan, Weiwei, Zhang, Ling, Zhang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982442/
https://www.ncbi.nlm.nih.gov/pubmed/32021306
http://dx.doi.org/10.2147/OTT.S230399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982442/
https://www.ncbi.nlm.nih.gov/pubmed/32021306
http://dx.doi.org/10.2147/OTT.S230399

Ejemplares similares